These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36815099)

  • 1. Uric Acid and Chronic Kidney Disease: Still More to Do.
    Johnson RJ; Sanchez Lozada LG; Lanaspa MA; Piani F; Borghi C
    Kidney Int Rep; 2023 Feb; 8(2):229-239. PubMed ID: 36815099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Goldberg A; Garcia-Arroyo F; Sasai F; Rodriguez-Iturbe B; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Am J Nephrol; 2021; 52(10-11):837-844. PubMed ID: 34673651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid and chronic kidney disease: which is chasing which?
    Johnson RJ; Nakagawa T; Jalal D; Sánchez-Lozada LG; Kang DH; Ritz E
    Nephrol Dial Transplant; 2013 Sep; 28(9):2221-8. PubMed ID: 23543594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid in metabolic syndrome: Does uric acid have a definitive role?
    Copur S; Demiray A; Kanbay M
    Eur J Intern Med; 2022 Sep; 103():4-12. PubMed ID: 35508444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.
    Ito S; Torii T; Nakajima A; Iijima T; Murano H; Horiuchi H; Yamanaka H; Honda M
    BMC Pediatr; 2020 Oct; 20(1):481. PubMed ID: 33059648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease.
    Sellmayr M; Hernandez Petzsche MR; Ma Q; Krüger N; Liapis H; Brink A; Lenz B; Angelotti ML; Gnemmi V; Kuppe C; Kim H; Bindels EMJ; Tajti F; Saez-Rodriguez J; Lech M; Kramann R; Romagnani P; Anders HJ; Steiger S
    J Am Soc Nephrol; 2020 Dec; 31(12):2773-2792. PubMed ID: 32938648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease　- Japanese Guideline on the Management of Asymptomatic Hyperuricemia.
    Hisatome I; Li P; Miake J; Taufiq F; Mahati E; Maharani N; Utami SB; Kuwabara M; Bahrudin U; Ninomiya H
    Circ J; 2021 Jan; 85(2):130-138. PubMed ID: 33342914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
    Takahashi T; Beppu T; Hidaka Y; Hosoya T
    Clin Exp Hypertens; 2021 Nov; 43(8):730-741. PubMed ID: 34425059
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia and chronic kidney disease: to treat or not to treat.
    Piani F; Sasai F; Bjornstad P; Borghi C; Yoshimura A; Sanchez-Lozada LG; Roncal-Jimenez C; Garcia GE; Hernando AA; Fuentes GC; Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    J Bras Nefrol; 2021; 43(4):572-579. PubMed ID: 33704350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Hyperuricemia and Chronic Kidney Disease: A Review.
    Prasad Sah OS; Qing YX
    Nephrourol Mon; 2015 May; 7(3):e27233. PubMed ID: 26290849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
    Kuriyama S
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):1-5. PubMed ID: 31754883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperuricemia and the metabolic syndrome].
    Mitu F; Drăgan MV
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1001-5. PubMed ID: 20191866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
    Petreski T; Ekart R; Hojs R; Bevc S
    Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
    Jeon HJ; Oh J; Shin DH
    PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Uric Acid and the Kidney.
    Ramos GK; Goldfarb DS
    Curr Rheumatol Rep; 2022 May; 24(5):132-138. PubMed ID: 35420373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia in renal disease patients.
    Bandúr Š
    Vnitr Lek; 2020; 66(4):259-266. PubMed ID: 32972192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.